M. Dal Pos

In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine

Daniela Bruttomesso, Dalia Crazzolara, Alberto Maran et al. · Diabetic Medicine · 2008 · 136 citations

Interactive Diary for Diabetes: A Useful and Easy-to-Use New Telemedicine System to Support the Decision-Making Process in Type 1 Diabetes

Maria Chiara Rossi, Antonio Nicolucci, Fabio Pellegrini et al. · Diabetes Technology & Therapeutics · 2009 · 70 citations

Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine–MDI)

Daniela Bruttomesso, M. Bonomo, Silvana Costa et al. · Diabetes & Metabolism · 2011 · 60 citations

Diabetes Management, Rapid-acting Insulin Analogues, Insulin Management +9

Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients

Gian Paolo Fadini, Natalino Simioni, Vera Frison et al. · Acta Diabetologica · 2013 · 50 citations

Obesity, Metabolic Syndrome, Nutrition +7

Correlation Between Baseline Characteristics and Clinical Outcomes in a Large Population of Diabetes Patients Treated with Liraglutide in a Real-World Setting in Italy

Annunziata Lapolla, Vera Frison, Michela Bettio et al. · Clinical Therapeutics · 2015 · 40 citations

Diabetes Management, Real-world Setting, Health Policy +9